Safety Study of Outpatient Treatment for Pulmonary Embolism

PHASE3CompletedINTERVENTIONAL
Enrollment

343

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions
Pulmonary Embolism
Interventions
OTHER

Outpatient care (vs traditional inpatient care)

Patients randomized to the outpatient arm are discharged from the emergency department within 24 hours after randomization. Patients randomized to the inpatient arm are admitted to the hospital and are discharged based on the decision of the managing physician at the hospital.

Trial Locations (19)

1011

University Hospital of Lausanne, Lausanne

1200

University Hospital Saint-Luc, Université Catholique de Louvain, Brussels

1211

University of Geneva, Geneva

3000

University of Leuven, Leuven

9007

Kantonsspital St. Gallen, Sankt Gallen

Unknown

Northwestern Memorial Hospital, Chicago

Carolinas Medical Center, Charlotte

UPMC Presbyterian Hospital, Pittsburgh

University of Angers, Angers

University of Argenteuil, Argenteuil

University of Boulogne, Boulogne

University Hospital of Brest, Brest

University of Clermont-Ferrand, Clermont-Ferrand

University of Dijon, Dijon

University of Nantes, Nantes

Hôpital Européen Georges Pompidou, Paris

Hôpital Henri Mondor, Créteil, Paris

Thiers, Thiers

Kantonsspital Baden, Baden

All Listed Sponsors
collaborator

Swiss National Science Foundation

OTHER

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of Lausanne Hospitals

OTHER

NCT00425542 - Safety Study of Outpatient Treatment for Pulmonary Embolism | Biotech Hunter | Biotech Hunter